The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests.

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Abstract Text:

Koji Endo,Noboru Suzuki,Osamu Yoshida,Hirayuki Sato,Yoshiaki Fujikura,Koji Endo,Noboru Suzuki,Osamu Yoshida,Hirayuki Sato,Yoshiaki Fujikura,

BACKGROUND/AIM: According to Fick's law of diffusion, the rate of transepidermal water loss (TEWL) is determined by a barrier component and a driving force component. The objective of this study is to propose novel indicators for the assessment of skin irritation potential from chemicals using these components. METHODS: Before and after acetone/ether (AE), sodium lauryl sulfate (SLS) and nicotinic acid methyl ester (NME) treatments, the apparent mass transfer coefficient of water, K, of the stratum corneum (SC) and the apparent water vapor pressure, P(d), at the interface between SC and epidermis were estimated as measures of the SC barrier and the driving force, respectively. RESULTS: After AE treatment, K showed marked increase and P(d) remained approximately constant. All participants reacted to NME with erythema and the laser-Doppler flowmetry (LDF) value peaked at around 30 min. While there was a change in P(d), which parallels with LDF changes, K showed little variation. Repeated SLS treatment induced a slight increase in P(d) besides an increase in K. In the meantime, all participants reacted with subtle erythema. CONCLUSIONS: Our results suggest that not only the SC barrier but also the driving force determines variations in the TEWL rates during skin irritant tests. Together, K and P(d) will provide us with invaluable information about skin condition.

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Publishing Authors By Initials

K Endo,N Suzuki,O Yoshida,H Sato,Y Fujikura,K Endo,N Suzuki,O Yoshida,H Sato,Y Fujikura,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Skin research and technology : official journal of

VOLUME: 13

Page Numbers: 425-35

Journal Abbreviation:

ISSN: 0909-752X

DAY: 2

MONTH: Nov

YEAR: 2007

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9504453

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests.

AFFILIATION: Analytical Research Center, KAO Corporation, Tochigi, Japan. endo.koji@kao.co.jp

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Skin Res Technol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests Related Publications

• Contraction of tubulointerstitial fibrosis tissue in diabetic nephropathy, as demonstrated in an in vitro fibrosis model.
• Morphological and functional changes of the rat parotid glandular cells by clipping and reopening the parotid duct, using HAM8 antibody.
• Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
• Specificity of the fatty acyl moieties of diacylglycerol for the activation of calcium-activated, phospholipid-dependent protein kinase.
• The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests.